Brief: Addex Gabab Positive Allosteric Modulator Demonstrates Promise In Alcohol Use Disorder
16/02/2021 06:04
Feb 16 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* ADDEX GABAB POSITIVE ALLOSTERIC MODULATOR DEMONSTRATES
PROMISE
IN ALCOHOL USE DISORDER
Source text for Eikon: ID:nGNEc3DWpt
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand